A clinical trial report of autologous bone marrow-derived mesenchymal stem cell transplantation in patients with spinal cord injury

Experimental and Therapeutic Medicine

Volumn 6, Issue 1, 2013, Pages 140-146

  Jiang, Pu Cha ^a   Xiong, Wen Ping ^a   Wang, Ge ^a   Ma, Chao ^a   Yao, Wei Qi ^a   Kendell, Steven F ^c   Mehling, Brian M ^c   Yuan, Xian Hou ^d   Wu, Dong Cheng ^a,b  

^a WUHAN UNIVERSITY   (China)

^b Department of Stem Cells   (China)

^c Blue Horizon International   (United States)

^d ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AMERICAN SPINAL INJURY ASSOCIATION IMPAIRMENT SCALE; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BARTHEL INDEX; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; ERECTILE DYSFUNCTION; FEMALE; FEVER; HEADACHE; HUMAN; INTESTINE FUNCTION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE TONE; NERVE FUNCTION; NEUROLOGY; PAIN; PAIN ASSESSMENT; PARESTHESIA; PROGNOSIS; SCHOOL CHILD; SPINAL CORD INJURY; URINARY TRACT FUNCTION;

EID: 84878201980     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1083     Document Type: Article

References (30)

1. Barnabé-Heider F and Frisén J: Stem cells for spinal cord repair. Cell Stem Cell 3: 16-24, 2008.
2. Lim PA and Tow AM: Recovery and regeneration after spinal cord injury: a review and summary of recent literature. Ann Acad Med Singapore 36: 49-57, 2007.
3. Goldman S: Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol 23: 862-871, 2005.
4. Harting MT, Baumgartner JE, Worth LL, et al: Cell therapies for traumatic brain injury. Neurosurg Focus 24: E18, 2008.
5. Park HC, Shim YS, Ha Y, et al: Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng 11: 913-922, 2005.
6. Zhao CH (ed): Theory, Technology and Clinical of Stem Cells. Beijing: Chemical Industry Press, Beijing, 2006.
7. Satake K, Lou J and Lenke LG: Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue. Spine (Phila Pa 1976) 29: 1971-1979, 2004.
8. Koda M, Nishio Y, Kamada T, et al: Granulocyte colony stimulating (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice. Brain Res 1149: 223-231, 2007.
9. Parr AM, Kulbatski I, Zahir T, et al: Transplanted spinal cord-derived neural stem/progenitor cells promote early functional recovery after rat spinal cord injury. Neuroscience 155: 760-770, 2008.
10. Julia PE and Othman AS: Barriers to sexual activity: counselling spinal cord injured women in Malaysia. Spinal Cord 49: 791-794, 2011.
11. Wrigley PJ, Press SR, Gustin SM, et al: Neuropathic pain and primary somatosensory cortex reorganization following spinal cord injury. Pain 141: 52-59, 2009.
12. Kim HS, Kim NH, Lee HM, Park HW, Ha JW and Park JO: Sexual dysfunction in men with paraparesis in lumbar burst fractures. Spine (Phila Pa 1976) 25: 2187-2190, 2000.
13. Park WB, Kim SY, Lee SH, Kim HW, Park JS and Hyun JK: The effect of mesenchymal stem cell transplantation on the recovery of bladder and hindlimb function after spinal cord contusion in rats. BMC Neurosci 11: 119, 2010.
14. Novikova LN, Brohlin M, Kingham PJ, Novikov LN and WibergM: Neuroprotective and growth-promoting effects of bone marrow stromal cells after cervical spinal cord injury in adult rats. Cytotherapy 13: 873-887, 2011.
15. Mothe AJ, Bozkurt G, Catapano J, et al: Intrathecal transplantation of stem cells by lumbar puncture for thoracic spinal cord injury in the rat. Spinal Cord 49: 967-973, 2011.
16. Nishida H, Nakayama M, Tanaka H, et al: Evaluation of transplantation of autologous bone marrow stromal cells into the cerebrospinal fluid for treatment of chronic spinal cord injury in dogs. Am J Vet Res 72: 1118-1123, 2011.
17. Deng YB, Yuan QT, Liu XG, et al: Functional recovery after rhesus monkey spinal cord injury by transplantation of bone marrow mesenchymal-stem cell-derived neurons. Chin Med J (Engl) 118: 1533-1541, 2005.
18. Yoon SH, Shim YS, Park YH, et al: Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells 25: 2066-2073, 2007.
19. Geffner LF, Santacruz P, Izurieta M, et al: Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant 17: 1277-1293, 2008.
20. Kumar AA, Kumar SR, Narayanan R, et al: Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data. Exp Clin Transplant 7: 241-248, 2009.
21. Chernykh ER, Stupak VV, Muradov GM, et al: Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients. Bull Exp Biol Med 143: 543-547, 2007.
22. Saito F, Nakatani T, Iwase M, et al: Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report. J Trauma 64: 53-59, 2008.
23. Kishk NA, Gabr H, Hamdy S, et al: Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury. Neurorehabil Neural Repair 24: 702-708, 2010.
24. Sharp J, Frame J, Siegenthaler M, et al: Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells 28: 152-163, 2010.
25. Hwang DH, Kim BG, Kim EJ, et al: Transplantation of human neural stem cells transduced with Olig2 transcription factor improves locomotor recovery and enhances myelination in the white matter of rat spinal cord following contusive injury. BMC Neurosci 10: 117, 2009.
26. Keirstead HS, Nistor G, Bernal G, et al: Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. JNeurosci 25: 4694-4705, 2005.
27. Vaquero J, Zurita M, Oya S and Santos M: Cell therapy using bone marrow stromal cells in chronic paraplegic rats: systemic or local administration? Neurosci Lett 398: 129-134, 2006.
28. Akiyama Y, Radtke C and Kocsis JD: Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci 22: 6623-6630, 2002.
29. Park HW, Lim MJ, Jung H, et al: Human mesenchymal stem cell-derived Schwann cell-like cells exhibit neurotrophic effects, via distinct growth factor production, in a model of spinal cord injury. Glia 58: 1118-1132, 2010.
30. Weimann JM, Johansson CB, Trejo A and Blau HM: Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant. Nat Cell Biol 5: 959-966, 2003.